Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Atlas Venture
Cambridge, Massachusetts, United Statesatlasventure.com ↗
- Ownership
- Private
- Employees
- ~40
- Development stage
- Other
01
Overview
Atlas Venture itself does not conduct clinical trials but has enabled the development of at least 25 approved medicines through its investments. Its portfolio companies have achieved significant milestones including IPOs and major M&A exits. Recent highlights include FDA approvals for CRISPR-based gene editing therapies and large licensing/acquisition deals for drugs targeting TYK2 kinase and weight loss pathways.
- Therapeutic areas
- Metabolic DisordersImmunologyOtherOncologyRare Diseases
- Modalities
- Small moleculeMonoclonal antibodyGene therapyRNA therapyRadiopharmaceuticals
- Industry
- Investors
02
Partnerships
AbCellera Biologics Inc. – multi-target partnership to discover therapeutic antibodies for up to three drug targets with commercialization by an Atlas-backed company
Beyond the preview
Go deeper on Atlas Venture.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Atlas Venture.